Evidence map›Paper›PMID 36558884›Full record

ArticlePathogens (Basel, Switzerland)2022

Dysbiosis in Head and Neck Cancer: Determining Optimal Sampling Site for Oral Microbiome Collection.

Dheeraj Pandey, Michal Szczesniak, Julia Maclean, Howard Chi Ho Yim, Fan Zhang, Peter Graham, Emad M El-Omar, Peter Wu

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Dheeraj PandeySt George and Sutherland Clinical Campuses, School of Clinical Medicine, University of New South Wales, Sydney 2052, Australia.ORCID 0000-0002-9981-0235
Michal SzczesniakSt George and Sutherland Clinical Campuses, School of Clinical Medicine, University of New South Wales, Sydney 2052, Australia.
Julia MacleanSt George and Sutherland Clinical Campuses, School of Clinical Medicine, University of New South Wales, Sydney 2052, Australia.
Howard Chi Ho YimSt George and Sutherland Clinical Campuses, School of Clinical Medicine, University of New South Wales, Sydney 2052, Australia.ORCID 0000-0002-2076-4361
Fan ZhangSt George and Sutherland Clinical Campuses, School of Clinical Medicine, University of New South Wales, Sydney 2052, Australia.
Peter GrahamSt George and Sutherland Clinical Campuses, School of Clinical Medicine, University of New South Wales, Sydney 2052, Australia.ORCID 0000-0002-4957-4895
Emad M El-OmarSt George and Sutherland Clinical Campuses, School of Clinical Medicine, University of New South Wales, Sydney 2052, Australia.ORCID 0000-0002-0011-3924
Peter WuSt George and Sutherland Clinical Campuses, School of Clinical Medicine, University of New South Wales, Sydney 2052, Australia.
Sutherland Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent research suggests that dysbiosis of the oral microbial community is associated with head and neck cancer (HNC). It remains unclear whether this dysbiosis causes chemo-radiotherapy (CRT)-related complications. However, to address this question, it is essential to determine the most representative oral site for microbiome sampling. In this study, our purpose was to determine the optimal site for oral sample collection and whether the presence of HNC is associated with altered oral microbiome from this site. In 21 newly diagnosed HNC patients and 27 healthy controls, microbiome samples were collected from saliva, swabs from buccal mucosa, tongue, hard palate, faucial pillars and all mucosal sites combined. Microbial DNA was extracted and underwent 16S rRNA amplicon gene sequencing. In healthy controls, analysis of observed taxonomic units detected differences in alpha- and beta-diversity between sampling sites. Saliva was found to have the highest intra-community microbial diversity and lowest within-subject (temporal) and between-subject variance. Feature intersection showed that most species were shared between all sites, with saliva demonstrating the most unique species as well as highest overlap with other sites. In HNC patients, saliva was found to have the highest diversity but differences between sites were not statistically significant. Across all sites, HNC patients had lower alpha diversity than healthy controls. Beta-diversity analysis showed HNC patients' microbiome to be compositionally distinct from healthy controls. This pattern was confirmed when the salivary microbiome was considered alone. HNC patients exhibited reduced diversity of the oral microbiome. Salivary samples demonstrate temporal stability, have the richest diversity and are sufficient to detect perturbation due to presence of HNC. Hence, they can be used as representative oral samples for microbiome studies in HNC patients.

Indexed as

chemoradiation therapydysbiosishead and neck canceroral microbiomesalivary microbiome

Identifiers

PMID36558884
PMCPMC9785010
OpenAlexW4312212027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.